Holzer RJ - Search Results

1

Transcatheter pulmonary valve implantation: valve technology and procedural outcome.

Salavitabar A, Flynn P, Holzer RJ. Salavitabar A, et al. Among authors: holzer rj. Curr Opin Cardiol. 2017 Nov;32(6):655-662. doi: 10.1097/HCO.0000000000000444. Curr Opin Cardiol. 2017. PMID: 28723838 Review.

2

Interventional approach to congenital heart disease.

Holzer R, Hijazi ZM. Holzer R, et al. Curr Opin Cardiol. 2004 Mar;19(2):84-90. doi: 10.1097/00001573-200403000-00003. Curr Opin Cardiol. 2004. PMID: 15075731 Review.

3

The Medtronic Melody® transcatheter pulmonary valve implanted at 24-mm diameter--it works.

Cheatham SL, Holzer RJ, Chisolm JL, Cheatham JP. Cheatham SL, et al. Among authors: holzer rj. Catheter Cardiovasc Interv. 2013 Nov 1;82(5):816-23. doi: 10.1002/ccd.24821. Epub 2013 Aug 12. Catheter Cardiovasc Interv. 2013. PMID: 23359563

4

Transcatheter pulmonary valve replacement: State of the art.

Holzer RJ, Hijazi ZM. Holzer RJ, et al. Catheter Cardiovasc Interv. 2016 Jan 1;87(1):117-28. doi: 10.1002/ccd.26263. Epub 2015 Oct 1. Catheter Cardiovasc Interv. 2016. PMID: 26423185 Review.

5

The Deconditioning Effect of the COVID-19 Pandemic on Unaffected Healthy Children.

Dayton JD, Ford K, Carroll SJ, Flynn PA, Kourtidou S, Holzer RJ. Dayton JD, et al. Among authors: holzer rj. Pediatr Cardiol. 2021 Mar;42(3):554-559. doi: 10.1007/s00246-020-02513-w. Epub 2021 Jan 4. Pediatr Cardiol. 2021. PMID: 33394120 Free PMC article.

6

Coronary Artery Dilation in an Asymptomatic Pediatric Patient with COVID19 Antibodies.

Gerber N, Flynn PA, Holzer RJ. Gerber N, et al. Among authors: holzer rj. Pediatr Cardiol. 2021 Feb;42(2):460-462. doi: 10.1007/s00246-021-02566-5. Epub 2021 Feb 6. Pediatr Cardiol. 2021. PMID: 33547936 Free PMC article.

7

Catheterization for Congenital Heart Disease Adjustment for Risk Method II.

Quinn BP, Gunnelson LC, Kotin SG, Gauvreau K, Yeh MJ, Hasan B, Lozier J, Barry OM, Shahanavaz S, Batlivala SP, Salavitabar A, Foerster S, Goldstein B, Divekar A, Holzer R, Nicholson GT, O'Byrne ML, Whiteside W, Bergersen L. Quinn BP, et al. Circ Cardiovasc Interv. 2024 Mar;17(3):e012834. doi: 10.1161/CIRCINTERVENTIONS.123.012834. Epub 2024 Jan 23. Circ Cardiovasc Interv. 2024. PMID: 38258562

8

Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry.

Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM; Amplatzer Muscular Ventricular Septal Defect Investigators. Holzer R, et al. J Am Coll Cardiol. 2004 Apr 7;43(7):1257-63. doi: 10.1016/j.jacc.2003.10.047. J Am Coll Cardiol. 2004. PMID: 15063439 Free article.

9

Device closure of iatrogenic membranous ventricular septal defects after prosthetic aortic valve replacement using the Amplatzer membranous ventricular septal defect occluder.

Holzer R, Latson L, Hijazi ZM. Holzer R, et al. Catheter Cardiovasc Interv. 2004 Jun;62(2):276-80. doi: 10.1002/ccd.20047. Catheter Cardiovasc Interv. 2004. PMID: 15170726

10

"Hybrid" stent delivery in the pulmonary circulation.

Holzer RJ, Chisolm JL, Hill SL, Olshove V, Phillips A, Cheatham JP, Galantowicz M. Holzer RJ, et al. J Invasive Cardiol. 2008 Nov;20(11):592-8. J Invasive Cardiol. 2008. PMID: 18987400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page